The negative effect of renin-angiotensin-aldosterone drugs (RAAS) on COVID-19 outcome reported in several studies at the beginning of the pandemic brough attention to a possible relationship between pretreatment with some drug groups and COVID-19 outcome. Here, REN is linked to COVID-19.